The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives

Cancer Letters

Volumn 152, Issue 2, 2000, Pages 201-209

  Tunca, Berrin ^a   Egeli, Ünal ^a   Zorluoglu, Abdullah ^a   Yilmazlar, Tuncay ^a   Yerci, Ömer ^a   Kizil, Ayhan ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Fragile sites; Genetic susceptibility; Rectum cancer

Indexed keywords

APHIDICOLIN; BROXURIDINE; CAFFEINE;

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FAMILY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LYMPHOCYTE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RECTUM CANCER;

ADULT; AGED; APHIDICOLIN; BROMODEOXYURIDINE; CAFFEINE; CASE-CONTROL STUDIES; CELLS, CULTURED; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; DNA DAMAGE; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOCYTES; MALE; METAPHASE; MIDDLE AGED; RECTAL NEOPLASMS;

EID: 0034194842     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00334-7     Document Type: Article

References (33)

1. Sutherland G.R. Heritable fragile sites on human chromosomes I. Factors affecting expression in lymphocyte culture, Am. J. Hum. Genet. 31:1979;125-135.
2. Hecht F. Fragile sites, cancer chromosome breakpoints, and oncogenes all cluster in light G bands. Cancer Genet. Cytogenet. 31:1988;17-24.
3. Ong S.T., Fong K.M., Bader S.A., Minna J.D., Le Beau M.M., McKeithan T.W., Rassool F.V. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines, Genes Chromosomes Cancer. 20:1997;16-23.
4. Le Beau M.M. Chromosomal fragile sites and cancer specific breakpoints. Cancer Genet. Cytogenet. 31:1988;55-61.
5. Zimonjic D.B., Druck T., Ohta M., Kastury K., Croce C.M., Popescu N.C., Huebner K. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene, Cancer Res. 57:1997;1166-1170.
6. Cecener G., Çeçener, Egeli Ü, Taşdelen İ, Tunca B., Duman H., Kizil A. Common fragile site expression and genetic predisposition to breast cancer. Teratog. Carcinog. Mutag. 18:1998;279-291.
7. Tunca B., Egeli Ü., Zorluo A. Zorluoglu. T. Yilmazlar, Ö. Yerci, A. Kizil, The expression frequency of common fragile sites and genetic predisposition to colon cancer, Cancer Genet. Cytogenet. 2000;. in press.
8. J.R. Zarr, Biostatistical Analysis, 2nd Edition, Prentice-Hall, Englewood Cliffs, New Jersey, 1984.
9. Paris Conference, Standardization in human cytogenetics, Cytogenetics, 11 (1972) 313-362.
10. Dave B.J., Hsu T.C., Hong W.K., Pathak S. Non-random distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. Int. J. Oncol. 5:1994;733-740.
11. Hsu T.C., Johnnston D.A., Cherry L.M., Ramkissoon D., Schamz S., Jessup J.M., Winn R.J., Shirley L., Furlong C. Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogens. Int. J. Cancer. 43:1989;403-409.
12. Hsu T.C., Spitz M.R., Schantz S.P. Mutagen sensitivity: A biological marker of cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 1:1991;83-89.
13. Pathak S., Goodacre A. Specific chromosome anomalies and predisposition to human breast, renal cell and colorectal carcinomas, Cancer Genet. Cytogenet. 19:1986;29-36.
14. Pazy-Mino C., Penaherra S., Sanches E., Cordova A., Gutierrez S., Ocampo L., Leone P.E. Comparative study of chromosome aberrations induced with aphidicolin in women affected by breast cancer and cervix uterine cancer. Cancer Genet. Cytogenet. 94:1997;120-124.
15. Porfirio B., Paladini P., Maccherini M., Gotti G., Cintorino M., De Marchi M. Patients with different lung cancer show expression of fra(3)(p14) in aphidicolin treated lymphocytes cultures. Cancer Genet. Cytogenet. 43:1989;95-101.
16. Ardisia C., Venti G., Colozza M.V., Breschi C., Porfirio B., Davis S., Tanoto M., Donti E. Expression of aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer. Cancer Genet. Cytogenet. 67:1993;113-116.
17. Liu C., Wang G., Li P. The expression frequency of common fragile sites and genetic susceptibility to lung cancer. Cancer Genet. Cytogenet. 42:1989;107-117.
18. Vernole P., Tedeschi B., Caporossi D., Nicoletti B. A study on lymphocytes of neuroblastoma patients. Cancer Genet. Cytogenet. 36:1988;13-23.
19. Egeli Ü., Karadag M., Tunca B., Özyardimci N. The expression of common fragile sites and genetic predisposition to squamous cell lung cancers. Cancer Genet. Cytogenet. 95:1997;153-158.
20. Simmers R.N., Sutherland G.R., West A., Richards R.I. Fragile sites at 16q22 are not at the breakpoint of the chromosomal rearrangements in acute myelomonocytic leukaemia. Science. 236:1987;92-94.
21. Sutherland G.R. Fragile sites and cancer breakpoints. Cancer Genet. Cytogenet. 31:1988;5-7.
22. Naylor S.L., Johnson B., Minna J.D., Sakaguchi A.Y. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature (Lond.). 329:1987;451-454.
23. Brauch H., Johnson B., Hovis J., Yano T., Gazdar A., Pettengill O.S., Graziano S., Sorenson G.D., Poieesz B.J., Minna J., Linehan M., Zbar B. Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. N. Engl. J. Med. 317:1987;1109-1113.
24. Zbar B., Brauch H., Talmadge C., Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature (Lond.). 327:1987;721-724.
25. Zeiger M.A., Gnarra J.R., Zbar B., Linehan W.M., Pass H.I. Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors. Genes Chromosomes Cancer. 11:1994;15-20.
26. Zeiger M.A., Zbar B., Keiser H., Linehan W.M., Gnarra J.R. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma, Genes Chromosomes Cancer. 13:1995;151-156.
27. Mooibroek H., Osinga J., Postmus P.E., Carritt B., Buys C.H. Loss of heterozygosity for a chromosome 3 sequence presumably at 3p21 in small cell lung cancer. Cancer Genet. Cytogenet. 27:1987;361-365.
28. Kastury K., Baffa R., Duck T., Ohta M., Cotticelli M.G., Inou H., Negrin M., Rugg M., Huang D., Croce C.M., Palazzo J., Huebner K. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines, Cancer Res. 56:1996;978-983.
29. Sozzi G., Veronese M., Begrini M., Baffa R., Cotticelli M., Inoue H., Tornielli S., Pilotti S., De Gregori L., Pastorino U., Pierotti M., Ohta M., Huebner K., Croce C. The FHIT gene at 3p14.2 is abnormal in lung cancer, Cell. 85:1996;17-26.
30. Thiagalingam S., Lisitsyn N.A., Hamaguchi M., Wigler M.H., Willson J.K.V., Markowitz S.D., Leach F.S., Kinzler K.W., Vogelstein B. Evaluation of the FHIT gene in colorectal cancers. Cancer Res. 56:1996;2936-2939.
31. Baba S. Recent advances in molecular genetics of colorectal cancer. World. J. Surg. 21:1997;678-687.
32. Su L.K., Vogelstein B., Kinzler K.W. Association of the APC tumor suppressor protein with catenins. Science. 262:1993;1734-1737.
33. Marra G., Boland C.R. Hereditary non-polyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J. Natl. Cancer Inst. 87:1995;1114-1125.